Oracle Health Sciences received superior marks in 'clinical trials value chain coverage' which included pre-clinical, clinical trials, pharmacovigilance and regulatory affairs.
Unlike other reports and analyses that rank solution providers solely based on revenue, Everest Group assesses companies based on market impact (market adoption, value delivered and portfolio mix) as well as vision and capability (vision and strategy, functionality, flexibility and ease of deployment, engagement and commercial model and support) to evaluate marketplace success.
'After evaluating Oracle's vision and capability as well as market impact for their Clinical One Platform, which is approaching clinical technology in a new and innovative manner, we placed them as a Leader. In addition to their market penetration, Oracle's breadth and depth of capabilities represent what we consider to be a leading solution in the eClinical space,' said Nitish Mittal, Practice Director, Everest Group.
Oracle Corporation published this content on 14 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 November 2017 13:14:05 UTC.
Original documenthttps://www.oracle.com/corporate/pressrelease/oracle-health-sciences-top-leader-on-everest-group-peak-matrix-111417.html
Public permalinkhttp://www.publicnow.com/view/07367EE81E3E82DBEEECECBD41D41C603BE8A92A